Cargando…

Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence

INTRODUCTION: Although the treatment success of long-term growth hormone therapy (GHT) is dependent on maintaining patients’ adherence to treatment, marked variations in adherence levels among children with GHT (eg, 7–71% nonadherence) have been reported. Barriers to or promoters of GHT adherence ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Takasawa, Kei, Mabe, Hiroyo, Nagamatsu, Fusa, Amano, Naoko, Miyakawa, Yuichi, Sutani, Akito, Kagawa, Reiko, Okada, Satoshi, Tanahashi, Yusuke, Suzuki, Shigeru, Hiroshima, Shota, Nagasaki, Keisuke, Dateki, Sumito, Takishima, Shigeru, Takahashi, Ikuko, Kashimada, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404042/
https://www.ncbi.nlm.nih.gov/pubmed/37545653
http://dx.doi.org/10.2147/PPA.S417142
_version_ 1785085208541790208
author Takasawa, Kei
Mabe, Hiroyo
Nagamatsu, Fusa
Amano, Naoko
Miyakawa, Yuichi
Sutani, Akito
Kagawa, Reiko
Okada, Satoshi
Tanahashi, Yusuke
Suzuki, Shigeru
Hiroshima, Shota
Nagasaki, Keisuke
Dateki, Sumito
Takishima, Shigeru
Takahashi, Ikuko
Kashimada, Kenichi
author_facet Takasawa, Kei
Mabe, Hiroyo
Nagamatsu, Fusa
Amano, Naoko
Miyakawa, Yuichi
Sutani, Akito
Kagawa, Reiko
Okada, Satoshi
Tanahashi, Yusuke
Suzuki, Shigeru
Hiroshima, Shota
Nagasaki, Keisuke
Dateki, Sumito
Takishima, Shigeru
Takahashi, Ikuko
Kashimada, Kenichi
author_sort Takasawa, Kei
collection PubMed
description INTRODUCTION: Although the treatment success of long-term growth hormone therapy (GHT) is dependent on maintaining patients’ adherence to treatment, marked variations in adherence levels among children with GHT (eg, 7–71% nonadherence) have been reported. Barriers to or promoters of GHT adherence have been discussed and investigated, and digital health technologies, such as electronic GH injection devices, may have the potential to assess adherence to GHT more accurately. Thus, we conducted a multicenter, retrospective cohort study using GH injection log analysis of an electronic GH device, GROWJECTOR(®)L, to qualify adherence and explore the factors influencing adherence. METHODS: This study enrolled 41 patients (median[range] age, 5.8[3.0 ~ 17.0] years) with short stature from nine Japanese medical institutions. The injection log data (12–48 weeks) were read by smartphones and collected into the data center through a cloud server. RESULTS: Although cumulative adherence rates remained higher than 95% throughout the observation period, five (12.2%) patients had low adherence (<85%). Subsequently, subgroup and logistic regression analyses for exploring factors affecting adherence revealed that self-selection of GH device and irregular injection schedule (ie, frequent injections after midnight) significantly affected adherence rate (p=0.034 and 0.048, respectively). In addition, higher rates of irregular injections significantly affected low adherence (median[range], 11.26[0.79 ~ 30.50]% vs 0.26[0.00 ~ 33.33]%, p = 0.029). DISCUSSION: Our study indicated that injection log analysis using an electronic GH device could detect irregular injection schedules due to a night owl or disturbance in lifetime rhythm affecting low adherence and had significant potential to encourage collaborative monitoring of adherence with healthcare providers and patients themselves/caregivers, along with growing autonomy and shared decision-making. Our study suggests the significance of narrative and personal approaches to adherence of patients with GHT and the usefulness of digital devices for such an approach and for removing various barriers to patient autonomy, leading to improvement and maintenance of adherence.
format Online
Article
Text
id pubmed-10404042
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104040422023-08-06 Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence Takasawa, Kei Mabe, Hiroyo Nagamatsu, Fusa Amano, Naoko Miyakawa, Yuichi Sutani, Akito Kagawa, Reiko Okada, Satoshi Tanahashi, Yusuke Suzuki, Shigeru Hiroshima, Shota Nagasaki, Keisuke Dateki, Sumito Takishima, Shigeru Takahashi, Ikuko Kashimada, Kenichi Patient Prefer Adherence Original Research INTRODUCTION: Although the treatment success of long-term growth hormone therapy (GHT) is dependent on maintaining patients’ adherence to treatment, marked variations in adherence levels among children with GHT (eg, 7–71% nonadherence) have been reported. Barriers to or promoters of GHT adherence have been discussed and investigated, and digital health technologies, such as electronic GH injection devices, may have the potential to assess adherence to GHT more accurately. Thus, we conducted a multicenter, retrospective cohort study using GH injection log analysis of an electronic GH device, GROWJECTOR(®)L, to qualify adherence and explore the factors influencing adherence. METHODS: This study enrolled 41 patients (median[range] age, 5.8[3.0 ~ 17.0] years) with short stature from nine Japanese medical institutions. The injection log data (12–48 weeks) were read by smartphones and collected into the data center through a cloud server. RESULTS: Although cumulative adherence rates remained higher than 95% throughout the observation period, five (12.2%) patients had low adherence (<85%). Subsequently, subgroup and logistic regression analyses for exploring factors affecting adherence revealed that self-selection of GH device and irregular injection schedule (ie, frequent injections after midnight) significantly affected adherence rate (p=0.034 and 0.048, respectively). In addition, higher rates of irregular injections significantly affected low adherence (median[range], 11.26[0.79 ~ 30.50]% vs 0.26[0.00 ~ 33.33]%, p = 0.029). DISCUSSION: Our study indicated that injection log analysis using an electronic GH device could detect irregular injection schedules due to a night owl or disturbance in lifetime rhythm affecting low adherence and had significant potential to encourage collaborative monitoring of adherence with healthcare providers and patients themselves/caregivers, along with growing autonomy and shared decision-making. Our study suggests the significance of narrative and personal approaches to adherence of patients with GHT and the usefulness of digital devices for such an approach and for removing various barriers to patient autonomy, leading to improvement and maintenance of adherence. Dove 2023-08-01 /pmc/articles/PMC10404042/ /pubmed/37545653 http://dx.doi.org/10.2147/PPA.S417142 Text en © 2023 Takasawa et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Takasawa, Kei
Mabe, Hiroyo
Nagamatsu, Fusa
Amano, Naoko
Miyakawa, Yuichi
Sutani, Akito
Kagawa, Reiko
Okada, Satoshi
Tanahashi, Yusuke
Suzuki, Shigeru
Hiroshima, Shota
Nagasaki, Keisuke
Dateki, Sumito
Takishima, Shigeru
Takahashi, Ikuko
Kashimada, Kenichi
Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence
title Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence
title_full Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence
title_fullStr Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence
title_full_unstemmed Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence
title_short Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence
title_sort growth hormone injection log analysis with electronic injection device for qualifying adherence to low-irritant formulation and exploring influential factors on adherence
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404042/
https://www.ncbi.nlm.nih.gov/pubmed/37545653
http://dx.doi.org/10.2147/PPA.S417142
work_keys_str_mv AT takasawakei growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT mabehiroyo growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT nagamatsufusa growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT amanonaoko growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT miyakawayuichi growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT sutaniakito growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT kagawareiko growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT okadasatoshi growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT tanahashiyusuke growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT suzukishigeru growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT hiroshimashota growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT nagasakikeisuke growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT datekisumito growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT takishimashigeru growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT takahashiikuko growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence
AT kashimadakenichi growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence